Uncertainty in clinical trials: Absolute risk, relative risk and personalised predictive medicine

https://www.forbes.com/sites/peterubel/2017/12/18/how-a-leading-medical-journal-helped-a-pharmaceutical-company-exaggerate-its-medication-benefits/#577a8db47901